1. Introduction {#sec1}
===============

Breast cancer (BC) is the most common female malignancy in the majority of countries \[[@B1]\]. Arab populations suffer from lower but steadily rising BC incidence rates compared to their American and European counterparts, and the clinical characteristics of the disease also differ between the aforementioned populations \[[@B2]\]. Such population-level differences in BC predisposition have been attributed to genetics and have been widely investigated, with different mutations having different levels of association with BC \[[@B3]\]. Compounding this issue is the fact that Arab BC genetics are not well researched, and much less is known about the genes involved in BC progression and drug response in Arab patients \[[@B4]\].

The ATP binding cassette (ABC) transporters comprise seven subfamilies of membrane proteins that facilitate the transport and modulate the effects of a wide range of drugs and their metabolites \[[@B5], [@B6]\]. Remarkably, an overexpression of certain ABC transporters in cancer cell lines resulted in multidrug resistance (MDR) and a potential failure of chemotherapy \[[@B7], [@B8]\]. For example, the*ABCC1* gene, also known as multidrug resistance-associated protein 1 (*MRP1*), is associated with worsened prognoses in a wide range of tumors, while the*ABCC2* gene was found to contribute to drug resistance \[[@B9], [@B10]\]. Likewise, the*ABCB1*gene is highly polymorphic and induces chemoresistance by preventing drug accumulation in cancer cells \[[@B7]\]. In addition, the*ABCG2* gene, also known as the breast cancer resistance protein (*BCRP*), is responsible for the transport of many conventional chemotherapeutics and causes MDR in various cancer cells \[[@B11]\].

In the present study, four SNPs of ABC transporter genes, namely*ABCC1*,*ABCC2*,*ABCB1*, and*ABCG2*, were screened in Jordanian Arabs with and without breast cancer. Previous reports have indicated that these genes play a critical role in increasing tumor risk, especially in breast cancer \[[@B9], [@B11]\]. The aim of this study is to determine whether the aforementioned genes play a significant role in Jordanian breast cancer patients.

2. Materials and Methods {#sec2}
========================

2.1. Ethical Approval and Conduct {#sec2.1}
---------------------------------

The present study was given ethical approval by the Institutional Review Board (IRB) at Jordan University of Science and Technology. Written informed consent was obtained from all participants in this study before blood sample withdrawal.

2.2. Study Population and Design {#sec2.2}
--------------------------------

The study cohort consisted of 222 women diagnosed with breast cancer as well as 218 healthy matched volunteers. All participants were recruited from the Jordanian population and were of Arab descent. 5 ml of blood were withdrawn from each participant into EDTA tubes and refrigerated until DNA extraction.

2.3. Genomic Extraction and Genotyping {#sec2.3}
--------------------------------------

Genomic DNA was extracted from a total of 440 blood samples using the Wizard® Genomic DNA Purification Kit (Promega, USA). Extracted DNA was evaluated in terms of concentration (ng/*μ*l) and purity (A260/280) quantity using the Nano-Drop ND-1000 UV-Vis Spectrophotometer (BioDrop, UK). DNA samples were then loaded onto an agarose gel to confirm product quality. Samples that met our requirements were diluted using nuclease-free water for a final concentration of 20 ng/*μ*l and a final volume of 30 *μ*l. Genotyping was carried out by the Melbourne node of the Australian Genome Research Facility (AGRF) using the Sequenom MassARRAY® system (iPLEX GOLD) (Sequenom, San Diego, CA, USA).

2.4. Denomination of Genotypic-Phenotypic Correlation {#sec2.4}
-----------------------------------------------------

In this study, several clinical and pathological features of BC were investigated in correlation with the studied variants. Clinical and pathological information for patients was collected from their medical records. P values were selected to estimate the association between SNPs and risk of BC. The analyses were done per genotype.

2.5. Statistical Analysis {#sec2.5}
-------------------------

Case-control analyses were carried out using different statistical software. Allelic and genotypic frequencies were calculated using the Hardy-Weinberg equilibrium (HWE) equation (Court lab - HW calculator) (<http://www.oege.org/software/hwe-mr-calc.html>). The Statistical Package for the Social Sciences (SPSS), version 25.0 (SPSS, Inc., Chicago, IL) was used to calculate the p values that allowed discrimination between cases and controls in association with the genotype. It also facilitated the analysis of the different genotype models. On the other hand, genotype-phenotype assessment was performed using the Chi-Square test and ANOVA tests \[[@B12]\]. P value denoted statistical significance if they were less than 0.05.

3. Results {#sec3}
==========

3.1. ABC Transporter Variants and Their Minor Allele Frequencies (MAF) {#sec3.1}
----------------------------------------------------------------------

[Table 1](#tab1){ref-type="table"} displays the SNPs of the*ABCC1*,*ABCC2*,*ABCB1*, and*ABCG2* candidate genes. All of the polymorphic SNPs were tested for minor allele frequencies (MAF) and HWE p values in both the cases and controls ([Table 1](#tab1){ref-type="table"}).

3.2. Association between ABC Transporter SNPs and Breast Cancer (BC) {#sec3.2}
--------------------------------------------------------------------

The allelic and genotypic frequencies of the ABC transporter SNPs were determined for both cases and controls ([Table 2](#tab2){ref-type="table"}). All three*ABCB1* SNPs were found to be significantly associated with BC in Jordanian patients, with rs1045642, rs1128503, and rs2032582 having p values of 0.01164587, 0.01610842, and 0.03565022, respectively. [Figure 1](#fig1){ref-type="fig"} shows a representative scatter pattern for rs1045642 of*ABCB1*. In contrast, only the rs2032582 SNP of*ABCB1* showed a strong genotypic association with BC (p value = 1e^-8,^ OR =6.72, 95% CI = 4.27 to 10.57). rs2032582 is a triallelic polymorphism comprising the A, C, and T (minor) alleles (the homozygous TT variant was not estimated in the current study population). None of the other investigated SNPs showed any significant correlation with BC, as all the allelic and genotypic frequencies were greater than 0.05 ([Table 2](#tab2){ref-type="table"}).

Further genetic analyses were carried out to test for the association of different genetic models with BC. [Table 3](#tab3){ref-type="table"} summarizes three different genetic models and the chi-squared value for each. The*ABCG2* gene was excluded from the analysis because it expressed only two genotypes. For the*ABCC1*SNP rs4148351, Het (CT) versus Common Hz (CC) was found to be associated with BC in Jordanian Arabs (*χ*2 = 5.33; p value \<0.05). Similarly, for the*ABCB1* SNP rs1128503, the Rare Hz (AA) versus Common Hz (GG) model was related to BC in Jordanian Arabs (*χ*2 =4.52; p value \<0.05). No such association was found for any of the*ABCC2* SNPs ([Table 3](#tab3){ref-type="table"}).

3.3. Association between ABC Transporter SNPs and Major Prognostic Factors of Breast Cancer (BC) {#sec3.3}
------------------------------------------------------------------------------------------------

Certain clinical and pathological characteristics of BC serve as major prognostic factors for the disease that are exploited in the process of treatment selection. None of the*ABCC1*SNPs showed any significant association with the clinical characteristics of BC, but the*ABCC2*SNPs rs2273697 and rs717620 were found to be significantly associated with age at breast cancer diagnosis (p value = 0.042) and breastfeeding status (p value = 0.05), respectively ([Table 4](#tab4){ref-type="table"}). Meanwhile, the*ABCC1*SNP rs35628 was associated with the pathological characteristic of tumor size (p value = 0.014), while the*ABCC2*SNP rs2273697 was significantly associated with estrogen receptor status (p value = 0.013) ([Table 4](#tab4){ref-type="table"}).

Likewise, rs1045642 was the only*ABCB1* SNP to be significantly associated with a clinical characteristic of BC, namely, age at breast cancer diagnosis (p value = 0.029) ([Table 5](#tab5){ref-type="table"}). In contrast, rs2032582 was the only*ABCB1* SNP to show significant association with a pathological characteristic of BC, namely, tumor size (p value = 0.03) ([Table 5](#tab5){ref-type="table"}). The*ABCG2*SNP rs2231142 was found to be significantly associated with axillary lymph node status (p value = 0.001) but not with any clinical characteristic ([Table 5](#tab5){ref-type="table"}).

3.4. Association between ABC Transporter SNPs and Immunohistochemistry (IHC) Profiles of Breast Cancer (BC) {#sec3.4}
-----------------------------------------------------------------------------------------------------------

Different combinations of the progesterone receptor, estrogen receptor, and Her2/neu expression molecular markers gives rise to three different immunohistochemistry profiles: Luminal A, Luminal B, and Triple Negative. These profiles and their correlation with the investigated SNPs are displayed in Tables [4](#tab4){ref-type="table"} and [5](#tab5){ref-type="table"}. Only the*ABCC1*SNP rs35626 was found to be significantly correlated with the different IHC profiles (p value = 0.013).

4. Discussion {#sec4}
=============

In the present study, four ABC transporter genes were screened in female BC patients and healthy volunteers from Jordan. Three SNPs from each of the*ABCC1, ABCC2,*and*ABCB1*genes and one SNP from the*ABCG2* gene were investigated for their association with BC in patients of Jordanian-Arab descent.

The*ABCC1 (MRP1)*gene has been previously reported as being a predictor of hematological toxicity in BC patients undergoing certain chemotherapy regimens \[[@B13]\]. It has also been found to be involved in MDR development in cases of neuroblastoma \[[@B14]\]. Moreover,*ABCC1* expression was found to be increased in children with acute lymphoblastic leukemia, and*ABCC1*gene induction resulted in worsened disease-free and overall survival rates \[[@B15], [@B16]\]. Our results show that none of the three investigated*ABCC1* SNPs showed any significant association with the clinical and pathological characteristics of BC. However, we found that the*ABCC1*SNP rs35626 was significantly associated with different immunohistochemistry (IHC) profiles in Jordanian-Arab patients.

Similar to*ABCC1*, the*ABCC2*gene is involved in decreased recurrence-free survival in BC patients receiving tamoxifen \[[@B17]\]. Nuclear expression of*ABCC2* in BC cells was also found to be associated with worsened clinical outcome \[[@B18]\]. Our findings showed that the*ABCC2*SNP rs2273697 was significantly associated with age at breast cancer diagnosis. Furthermore, rs2273697 was in correlation with estrogen receptor status for genotype association, patients were categorized according to the expression of estrogen receptor (positive versus negative) and tested with regard to their genotypes. However, in this study only gender was matched for the analysis. In addition, rs717620 was associated with breastfeeding status.

Three*ABCB1* SNPs rs1045642, rs1128503, and rs2032582 have been suggested to play a role in altered doxorubicin pharmacokinetics in Asian BC patients \[[@B19]\]. In the present study, all three aforementioned*ABCB1*SNPs were significantly associated with BC in Jordanian Arabs. Moreover, the*ABCB1* SNPs rs1045642 and rs2032582 were significantly associated with age at breast cancer diagnosis and tumor size, respectively.

Overexpression of the*ABCG2*gene was implicated in developing flavopiridol resistance in BC cells \[[@B20]\]. The homozygous genotype (CC) of the*ABCG2* SNP rs2231142 of the*ABCG2*gene resulted in significantly reduced intestinal transport activity compared to the wildtype (AA) \[[@B21]\]. In Kurdish BC patients, the A allele of the rs2231142 SNP may be a risk factor for BC progression, while the C allele was associated with poorer responses to anthracyclines and paclitaxel \[[@B22]\]. In contrast, the homozygous (CC) genotype of the*ABCG2* SNP rs2231142 was significantly associated with longer progression-free survival in Han Chinese BC patients \[[@B23]\]. In the present study, the*ABCG2*SNP rs2231142 was found to be significantly associated with axillary lymph node status in Jordanian BC patients.

Conclusively, screening certain ABC transporter genes in BC patients and healthy volunteers from the Jordanian-Arab population revealed a number of interesting observations. Perhaps the most important finding was that the*ABCB1*SNPs were the only variants to be significantly associated with BC in Jordanian Arabs.
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###### 

Minor allele frequencies among breast cancer patients and healthy controls and the HWEc p value of ABC gene polymorphisms.

  Gene        SNP ID      SNP position ^a^   Cases (n = 222)   Controls (n = 218)                          
  ----------- ----------- ------------------ ----------------- -------------------- ------- ------ ------- -------
  ABCC1       rs35626     16076758           T                 0.38                 0.3     T      0.41    0.12
  rs35628     16077249    G                  0.1               0.049                G       0.11   0.27    
  rs4148351   16076711    T                  0.16              0.037                T       0.2    N/A     
                                                                                                           
  ABCC2       rs2273697   99804058           A                 0.25                 N/A     A      0.24    0.089
  rs3740065   99845936    G                  0.23              N/A                  G       0.21   0.066   
  rs717620    99782821    T                  0.12              0.75                 T       0.13   0.38    
                                                                                                           
  ABCB1       rs1045642   87509329           T                 0.35                 0.025   T      0.43    0.026
  rs1128503   87550285    A                  0.36              0.039                A       0.44   0.074   
  rs2032582   87531302    T                  0.03              0.4591               T       0.01   0.615   
                                                                                                           
  ABCG2       rs2231142   88131171           T                 0.04                 0.552   T      0.04    0.572

^a^Chromosome positions are based on NCBI Human Genome Assembly Build. ^b^MA: minor allele. ^c^MAF: minor allele frequency. ^d^HWE: Hardy--Weinberg equilibrium. N/A: not applicable.

###### 

Association of the investigated ABCC1, ABCC2, ABCB1, and ABCG2 SNPs and breast cancer (BC).

  Gene        SNP ID       Allelic and Genotypic Frequencies in Cases and Controls                                     
  ----------- ------------ --------------------------------------------------------- ------------ ------------ ------- -------
  *ABCC1*     rs35626      G                                                         283(0.65)    256 (0.59)   0.073   3.214
  T           155 (0.35)   180 (0.41)                                                                                  
  GG          95 (0.43)    81(0.37)                                                  0.216        3.063                
  GT          93 (0.42)    94(0.43)                                                                                    
  TT          31 (0.14)    43 (0.2)                                                                                    
  rs35628     A            394 (0.9)                                                 388 (0.89)   0.788        0.072   
  G           44 (0.1)     46 (0.11)                                                                                   
  AA          180(0.82)    175(0.81)                                                 0.820        0.395                
  AG          34(0.16)     38(0.18)                                                                                    
  GG          5(0.02)      4(0.02)                                                                                     
  rs4148351   C            369(0.84)                                                 346(0.8)     0.082        3.021   
  T           69 (0.16)    88 (0.2)                                                                                    
  CC          160 (0.73)   138 (0.64)                                                0.068        5.374                
  CT          49 (0.22)    70(0.32)                                                                                    
  TT          10 (0.05)    9(0.04)                                                                                     
                                                                                                                       
  *ABCC2*     rs2273697    G                                                         332(0.75)    331(0.76)    0.778   0.079
  A           108 (0.25)   103 (0.24)                                                                                  
  AA          13 (0.06)    17(0.08)                                                  0.412        1.773                
  GA          82 (0.37)    69(0.32)                                                                                    
  GG          125 (0.57)   131(0.6)                                                                                    
  rs3740065   A            341(0.77)                                                 345(0.79)    0.478        0.503   
  G           101(0.23)    91(0.21)                                                                                    
  AA          131(0.59)    141(0.65)                                                 0.285        2.51                 
  AG          79(0.36)     63(0.29)                                                                                    
  GG          11(0.05      14(0.06)                                                                                    
  s717620     C            387(0.88)                                                 377(0.87)    0.285        2.51    
  T           55(0.12)     57 (0.13)                                                                                   
  CC          170(0.77)    165(0.76)                                                 0.928        0.149                
  CT          47(0.21)     47(0.22)                                                                                    
  TT          4(0.02)      5(0.02)                                                                                     
                                                                                                                       
  *ABCB1*     rs1045642    C                                                         288(0.65)    248(0.57)    0.012   6.364
  T           152(0.35)    186(0.43)                                                                                   
  CC          102(0.46)    79(0.36)                                                  0.063        5.499                
  CT          84(0.38)     90(0.41)                                                                                    
  TT          34(0.15)     48(0.22)                                                                                    
  rs1128503   A            278(0.64)                                                 242(0.56)    *0.016*      5.791   
  G           158(0.36)    192(0.44)                                                                                   
  AA          36(0.17)     49(0.23)                                                  0.074        5.189                
  GA          86(0.39)     94(0.43)                                                                                    
  GG          96(0.44)     74(0.34)                                                                                    
  rs2032582   A            144(0.33)                                                 174(0.43)    *0.035*      6.668   
  C           284(0.65)    252(0.58)                                                                                   
  T           12(0.03)     6(0.01)                                                                                     
  AA          29(0.13)     41(0.19)                                                  *1e-8*       44.386               
  CA          82(0.37)     90(0.42)                                                                                    
  CC          97(0.44)     79(0.37)                                                                                    
  TA          49(0.02)     2(0.0093)                                                                                   
  TC          8(0.04)      4(0.02)                                                                                     
                                                                                                                       
  *ABCG2*     rs2231142    T                                                         17(0.04)     16(0.04)     0.902   0.015
  G           425 (0.96)   418 (0.96)                                                                                  
  GG          204(0.92)    201(0.93)                                                 0.899        0.016                
  GT          17(0.08)     16(0.07)                                                                                    

P value \<0.05 was considered as significant.

###### 

Genetic association analysis for the ABCC1, ABCC2, ABCB1, and ABCG2 SNPs using different genetic models.

  Gene                              SNP ID                        Category Test                 Odds Ratio   95% CI      Chi square*∗*
  --------------------------------- ----------------------------- ----------------------------- ------------ ----------- ---------------
  *ABCC1*                           rs35626                       Het (GT) vs. Common Hz (GG)   0.84         0.56-1.27   0.65
  Rare Hz (TT) vs. Het (GT)         0.73                          0.42-1.25                     1.31                     
  Rare Hz (TT) vs. Common Hz (GG)   0.61                          0.36-1.06                     3.04                     
  rs35628                           Het (AG) vs. Common Hz (AA)   0.87                          0.52-1.44    0.29        
  Rare Hz (GG) vs. Het (AG)         1.4                           0.35-5.63                     0.22                     
  Rare Hz (GG) vs. Common Hz (AA)   1.22                          0.32-4.6                      0.08                     
  rs4148351                         Het (CT) vs. Common Hz (CC)   0.6                           0.39-0.93    5.33        
  Rare Hz (TT) vs. Het (AG)         1.58                          0.6-4.19                      0.88                     
  Rare Hz (TT) vs. Common Hz (CC)   0.96                          0.38-2.43                     0.01                     
                                                                                                                         
  *ABCC2*                           rs2273697                     Het (GA) vs. Common Hz (GG)   1.55         0.71-3.42   1.21
  Rare Hz (AA) vs. Het (GA)         0.8                           0.54-1.2                      1.14                     
  Rare Hz (AA) vs. Common Hz (GG)   1.25                          0.58-2.68                     0.32                     
  rs3740065                         Het (GA) vs. Common Hz (AA)   1.35                          0.9-2.03     2.08        
  Rare Hz (GG) vs. Het (GA)         0.63                          0.27-1.48                     1.16                     
  Rare Hz (GG) vs. Common Hz (AA)   0.85                          0.37-1.93                     0.16                     
  rs717620                          Het (CT) vs. Common Hz (CC)   0.97                          0.61-1.53    0.02        
  Rare Hz (TT) vs. Het (CT)         0.8                           0.2-3.17                      0.1                      
  Rare Hz (TT) vs. Common Hz (CC)   0.78                          0.2-2.94                      0.14                     
                                                                                                                         
  *ABCB1*                           rs1045642                     Het (CT) vs. Common Hz (CC)   0.72         0.48-1.1    2.32
  Rare Hz (TT) vs. Het (CT)         0.85                          0.5-1.43                      0.39                     
  Rare Hz (TT) vs. Common Hz (CC)   0.61                          0.37-1.03                     3.46                     
  rs1128503                         Het (GA) vs. Common Hz (AA)   1.25                          0.74-2.1     0.68        
  Rare Hz (GG) vs. Het (GA)         1.42                          0.93-2.16                     2.65                     
  Rare Hz (GG) vs. Common Hz (AA)   1.77                          1.04-2.99                     4.52                     

*∗* For significant association *χ*2 should be \>3.84 with P\<0.025.

CI indicates confidence interval.

###### 

Association between different ABCC1 and ABCC2 SNP genotypes and the clinicopathological characteristics of breast cancer (BC).

  Clinical characteristics           *ABCC1*   *ABCC2*                           
  ---------------------------------- --------- --------- ------- ------- ------- -------
  Body mass index *∗∗*               0.535     0.116     0.068   0.813   0.461   0.084
                                                                                 
  Age at first pregnancy *∗∗*        0.990     0.624     0.358   0.381   0.921   0.458
                                                                                 
  Age at BC diagnosis *∗∗*           0.311     0.352     0.198   0.042   0.194   0.104
                                                                                 
  Allergy *∗*                        0.808     0.824     0.867   0.501   0.324   0.065
                                                                                 
  Age at menarche *∗∗*               0.219     0.824     0.373   0.820   0.747   0.611
                                                                                 
  Breastfeeding status *∗*           0.284     0.117     0.761   0.439   0.340   0.005
                                                                                 
  Age at menopause *∗∗*              0.437     0.665     0.373   0.115   0.155   0.251
                                                                                 
  Family history *∗*                 0.669     0.605     0.762   0.472   0.891   0.415
                                                                                 
  Comorbidity *∗*                    0.764     0.967     0.976   0.130   0.741   0.140
                                                                                 
  Smoking *∗*                        0.237     0.287     0.163   0.320   0.406   0.362
                                                                                 
  Pathological characteristics                                                   
                                                                                 
  Progesterone receptor status *∗*   0.292     0.516     0.244   0.610   0.823   0.423
                                                                                 
  Estrogen receptor status *∗*       0.730     0.550     0.562   0.013   0.839   0.125
                                                                                 
  HER2 *∗*                           0.146     0.500     0.330   0.441   0.226   0.842
                                                                                 
  IHC profile*∗*                     0.013     0.838     0.260   0.381   0.775   0.270
                                                                                 
  Tumor differentiation *∗*          0.754     0.940     0.963   0.768   0.718   0.431
                                                                                 
  Axillary lymph nodes *∗*           0.113     0.184     0.817   0.138   0.989   0.213
                                                                                 
  Tumor stage *∗*                    0.491     0.751     0.665   0.748   0.999   0.357
                                                                                 
  Histology classification *∗*       0.963     0.502     0.348   0.301   0.294   0.661
                                                                                 
  Tumor size *∗∗*                    0.888     0.014     0.968   0.720   0.576   0.922
                                                                                 
  Lymph node involvement *∗*         0.694     0.944     0.794   0.165   0.339   0.528

*∗* Pearson\'s chi-squared test was used to determine genotype-phenotype association.

*∗∗* Analysis of variance (ANOVA) test was used to determine genotype-phenotype association.

P value \<0.05 was considered as significant.

###### 

Association between different ABCB1 and ABCG2 SNP genotypes and the clinicopathological characteristics of breast cancer (BC).

  Clinical characteristics           *ABCB1*    *ABCG2*             
  ---------------------------------- ---------- --------- --------- -------
  Body mass index *∗∗*               0.298      0.383     0.180     0.164
                                                                    
  Age at first pregnancy *∗∗*        0.212      0.326     0.815     0.490
                                                                    
  Age at BC diagnosis *∗∗*           0.931      0.924     *0.029*   0.592
                                                                    
  Allergy *∗*                        0.310*∗*   0.331     0.169     0.511
                                                                    
  Age at menarche *∗∗*               0.508      0.525     0.115     0.947
                                                                    
  Breastfeeding status *∗*           0.708      0.291     0.665     0.553
                                                                    
  Age at menopause *∗∗*              0.746      0.258     0.676     0.563
                                                                    
  Family history *∗*                 0.585      0.626     0.469     0.481
                                                                    
  Comorbidity *∗*                    0.350      0.347     0.751     0.341
                                                                    
  Smoking *∗*                        0.462      0.365     .303      0.429
                                                                    
  Pathological characteristics                                      
                                                                    
  Progesterone receptor status *∗*   0.375      0.555     0.268     0.244
                                                                    
  Estrogen receptor status *∗*       0.470      0.480     0.299     0.312
                                                                    
  HER2 *∗*                           0.712      0.886     0.835     0.560
                                                                    
  IHC profile*∗*                     0.186      0.645     0.160     0.606
                                                                    
  Tumor differentiation *∗*          0.429      0.632     0.595     0.926
                                                                    
  Axillary lymph nodes *∗*           0..373     0.718     0.847     0.001
                                                                    
  Tumor stage *∗*                    0.700      0.705     0.723     0.722
                                                                    
  Histology classification *∗*       0.488      0.498     0.602     0.648
                                                                    
  Tumor size *∗∗*                    0.030      0.032     0.556     0.249
                                                                    
  Lymph node involvement *∗*         0.021      0..056    0.417     0.381

*∗* Pearson\'s chi-squared test was used to determine genotype-phenotype association.

*∗∗* Analysis of variance (ANOVA) test was used to determine genotype-phenotype association.

P value \<0.05 was considered as significant.
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